The KKH (Kaufmännische Krankenkasse) aims to establish discount agreements with all suitable pharmaceutical companies for the specified active ingredients under the Open-House procedure as per § 130a Abs. 8 SGB V. This process allows all eligible and interested pharmaceutical companies or groups to
138 days left to bid. Opened 1 years ago, deadline 31 Dec 2026.
The KKH (Kaufmännische Krankenkasse) is seeking to establish non-exclusive discount agreements with pharmaceutical companies for specific active ingredients under the Open-House procedure. This opportunity is open to all qualified pharmaceutical companies interested in entering into discount agreeme
The Kaufmännische Krankenkasse (KKH) aims to establish discount agreements with all suitable pharmaceutical companies for the specified active ingredients under Section 130a (8) of the Social Code Book V (SGB V) through an 'Open-House' procedure. This process allows all eligible and interested pharm
The KKH (Kaufmännische Krankenkasse) aims to establish discount agreements with all suitable pharmaceutical companies for the specified active ingredients under the Open-House procedure as per § 130a Abs. 8 SGB V. This process allows all eligible and interested pharmaceutical companies or groups to
The Kaufmännische Krankenkasse (KKH) aims to establish discount agreements with all suitable pharmaceutical companies for the specified active ingredients under the Open-House procedure as per § 130a paragraph 8 of the Social Code Book V. This process will provide uniform contract conditions and acc
UK Home Office seeks a global tuberculosis screening service provider to manage visa applicant testing across international locations through various delivery models.
Norfolk County Council is seeking a contractor to provide technology-enabled and virtual care services that help residents maintain independence and improve outcomes while remaining in their own homes.
Market engagement RFI for integrated criminal justice liaison, prison reentry and mental health treatment services across Lancashire and Cumbria, closing 4 September 2026.
UKHSA is seeking supplier participation in a market engagement exercise for Pralidoxime Chloride supply in 2026 through a formal Request for Information process.
